Vienna Insurance Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Vienna Insurance Group’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.37M	Hold	200,000	–	–	1.15%	20
2026 Q1	$4.67M	Hold	200,000	–	–	1.78%	21
2025 Q4	$4.2M	Hold	200,000	–	–	2.05%	19
2025 Q3	$3.08M	Hold	200,000	–	–	1.82%	19
2025 Q2	$1.87M	Hold	200,000	–	–	1.18%	17
2025 Q1	$2.46M	Buy	+200,000	New	+$2.82M	1.34%	18

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Vienna Insurance Group's SNDX Position: Q2 2026 in Review

Vienna Insurance Group held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 200,000 shares worth $4.37M. The position accounts for 1.15% of the portfolio, ranked #20.

Vienna Insurance Group first reported a position in SNDX in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.67M in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Vienna Insurance Group held 200,000 shares of Syndax Pharmaceuticals worth $4.37M as of Q2 2026.
Vienna Insurance Group left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
Syndax Pharmaceuticals made up 1.15% of Vienna Insurance Group's portfolio in Q2 2026, its #20 holding.
Vienna Insurance Group first reported a position in Syndax Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Vienna Insurance Group's Syndax Pharmaceuticals position peaked at $4.67M in Q1 2026.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Vienna Insurance Group's 13F filing for Q2 2026, filed 30 Jul 2026.